Cov ntaub ntawv yooj yim
Fmoc-Ile-Aib-OH - Tirzepatide Fragment Synthesis Intermediate (CAS 2171139-20-9)
Joy Biotech muab cov khoom siv siab -purity Fmoc-Ile-Aib-OH, ib qho kev xav tau ntawm dipeptide tsev thaiv siv hauvTirzepatide fragment synthesis. Nrog ntau dua lossis sib npaug li 98% HPLC purity, tswj Fmoc tiv thaiv kev ruaj ntseg, thiab cov ntaub ntawv tso tawm, qhov nruab nrab no yog tsim los rau cov khoom siv txhim khu kev qha-theem thiab kev daws teeb meem-theem peptide manufacturing.
CAS Nr.: 2171139-20-9
Purity:NLT 98.0% (HPLC)
Daim ntawv thov:Tirzepatide intermediate / Tirzepatide fragment synthesis
Kev Pabcuam:Ua ntej- kev txhawb nqa kev sim tshuaj & kev tsim qauv muaj
Specification
| Khoom npe | Fmoc-Ile-Aib-OH |
| CAS | 2171139-20-9 |
| Cov khoom kuaj | Txuj |
| Qhov tshwm sim | Dawb los yog tawm -dawb hmoov |
| Purity (HPLC) | 98.0% NLT |
| Cov ntsiab lus dej | 1.0% NMT |
| Assay | 98.0% NLT |
Batch ntaub ntawv muaj:
Certificate of Analysis (COA) ib tug ntau
HPLC chromatogram thiab MS spectrum
Residual solvent thiab elemental impurity cov ntaub ntawv (ntawm kev thov)
Cov ntaub ntawv ruaj khov txhawb nqa 2-8℃cia
The Aib Challenge in Tirzepatide Fragment Synthesis
Tirzepatide muaj tus yuam sijIle-Aibmotif uas -aminoisobutyric acid (Aib) qhia qhov tseem ceebsteric hindrancentawm -carbon. Qhov no quaternary center:
Txwv kev sib hloov ntawm qaum qaum thiab tuaj yeem ua kom qeeb txuas kinetics
Ua kom muaj kev pheej hmoo ntawm kev sib txuas tsis tiav thiab kev tshem tawm ib ntus
Xav tau ib lub tsev thaiv nrog siab purity thiab zoo -txhais stereochemistry
Fmoc-Ile-Aib-OH delivers thepre-formed Ile-Aib dipeptide, bypassing qhov nyuaj ncaj coupling ntawm Aib thiab txhim kho tag nrho fragment los ua ke efficiency. Peb cov khoom yog tsim nyob rau hauv kev tswj tej yam kev mob kom txo tau diastereomer tsim thiab residual impurities uas yuav cuam tshuam koj Tirzepatide fragment.
Fmoc Protection Stability - Tseem ceeb heev rau kev tiv thaiv kom huv
Pawg Fmoc ntawm Fmoc-Ile-Aib-OH yuav tsum nyob twj ywm tsis tu ncua los ntawm kev khaws cia, kev xa khoom, thiab kev sib txuas, tom qab ntawd raug tshem tawm kom huv si yam tsis muaj kev cuam tshuam rau Aib residue lossis cov saw peptide loj hlob.
Peb lub tswv yim tswj:
ruaj khov cia:Cov ntim ntim ntim ntawm 2-8℃tiv thaiv pawg Fmoc los ntawm kev tawg ntxov ntxov
Kev tswj dej noo:Cov ntsiab lus dej NMT 1.0% txo lub hauv paus-kuaj Fmoc poob
Kev taw qhia kev tuav:Tiv thaiv los ntawm cov hauv paus muaj zog, amines, thiab lub teeb ntev ntev
Deprotection compatibility:Cov txheej txheem piperidine / DMF; cov ntaub ntawv ruaj ntseg raws li SPPS cycles
Qhov no ua kom ntseeg tau tias muaj kev tiv thaiv kev tiv thaiv thiab tsawg dua cov khoom siv sab hauv lub sijhawmTirzepatide fragment synthesis.
Amino Acid Sequence Ntsiab Lus & Daim Ntawv Thov
Tirzepatide yog 39-amino-acid dual GIP/GLP-1 receptor agonist. CovIle-Aibdipeptide chav tsev pab txhawb rau cov pob txha txha caj qaum uas txhim kho metabolic stability thiab kev ua haujlwm receptor. Siv lub pre-assembled Fmoc-Ile-Aib-OH lub tsev thaiv:
Txo cov kauj ruam sib txuas thiab lub sijhawm voj voog hauv SPPS
Txhim kho cov txiaj ntsig ntawm Aib- muaj cov khoom tawg
Txhawb kev sib koom ua ke ntawm Tirzepatide thiab lwm yam analogs
Tej kev siv:
Khoom -phase peptide synthesis (SPPS) ntawm Tirzepatide fragments
Kev daws -phase fragment condensation
Cov txheej txheem kev txhim kho thiab ntsuas ntsuas - nce ntawm GLP-1/GIP dual agonists
Daim ntawv pov thawj kev tshawb fawb thiab kev tswj xyuas impurity
Ua ntej-Kev Pabcuam Kev Kho Mob
Joy Biotech txhawb nqa kojua ntej-kev sim tshuajcov kev pab cuam nrog ntau tshaj li cov khoom catalog:
Kev cai synthesisntawm Tirzepatide fragments thiab lwm yam intermediates
Scale -up:gram rau kilogram kom muaj nuj nqis nrog zoo ib yam
Cov ntaub ntawv txhawb nqa:COA, MSDS, kev ruaj ntseg cov ntaub ntawv, thiab impurity profiles rau IND-ua kom muaj kev tshawb fawb
Kev pab txhawb nqa:coupling thiab deprotection kev taw qhia los ntawm peb pab neeg peptide chemistry
Tsis pub twg paub:NDA- txhawb nqa kev sib koom tes rau cov kev pabcuam muaj tswv
Txawm hais tias koj tab tom txhim kho txoj hauv kev lossis npaj cov khoom siv ua ntej - kev soj ntsuam kuaj mob, peb pab koj txav nrawm dua nrog kev ntseeg siab Fmoc-Ile-Aib-OH.
Tuam txhab Profile
Joy Biotech, aims los sib koom Kev xyiv fab ntawm lub neej zoo nkauj thiab noj qab nyob zoo, yog tus kws tshaj lij ntawm cov khoom siv hauv tsev, cov khoom siv tshuaj xws li Fmoc-Ile-Aib-OH (CAS No is 2171139-20-9), Intermediates, APIs, Dietary supplements, Cosmetic ingredients etc.
Joy Biotech muab APIs, Pharmaceuticals Intermediate zoo li Tirzepatide intermediates, cov khoom xyaw tshuaj pleev ib ce, kev noj haus, kev cai synthesis, CMO thiab CDMO.
Peb tuaj yeem tsim cov khoom sib txuas raws li koj xav tau. Los yog tsim cov khoom raws li koj cov pob khoom siv tshuab.
Peb pab pawg R&D, coj los ntawm tus kws tshaj lij-tus kws kho mob, muaj cov kws kho mob, masters, Bachelors hauv kev lag luam tshuaj, chemistry, Biology.



Rau cov khoom raws li kev tiv thaiv patent, peb muab cov khoom siv raw rau kev tshawb fawb nkaus xwb.

Tiv tauj peb
Email: sales@joybiotech.com
Whatsapp: +8615968534750
Wechat: mt20230523
Peb Cov Ntawv Pov Thawj
Peb cov ntawv pov thawj ua tiav thiab ntseeg tau


Cim npe nrov: Fmoc-Ile-Aib-OH CAS: 2171139-20-9, China Fmoc-Ile-Aib-OH CAS: 2171139-20-9 manufacturers, lwm tus, Hoobkas


![Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH](/uploads/43157/small/fmoc-l-lys-c20-otbu-glu-otbu-aeea-aeea-oh1fa7b.jpg)



